Galecteye Pharma ApS
Credit rating
Company information
About Galecteye Pharma ApS
Galecteye Pharma ApS (CVR number: 38248243) is a company from KØBENHAVN. The company recorded a gross profit of -6.2 kDKK in 2020. The operating profit was -6.2 kDKK, while net earnings were -7.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was -5.2 %, which can be considered poor and Return on Equity (ROE) was -65.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 6.4 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. Galecteye Pharma ApS's liquidity measured by quick ratio was 18.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2017 | 2018 | 2019 | 2020 | |
---|---|---|---|---|
Volume | ||||
Net sales | ||||
Gross profit | -17.11 | -10.04 | -5.00 | -6.25 |
EBIT | -17.11 | -10.04 | -5.00 | -6.25 |
Net earnings | -18.15 | -11.05 | -6.02 | -7.28 |
Shareholders equity total | 31.85 | 20.80 | 14.78 | 7.50 |
Balance sheet total (assets) | 142.26 | 130.35 | 124.10 | 117.85 |
Net debt | -41.22 | -28.30 | -21.03 | -13.75 |
Profitability | ||||
EBIT-% | ||||
ROA | -12.0 % | -7.4 % | -3.9 % | -5.2 % |
ROE | -57.0 % | -42.0 % | -33.8 % | -65.4 % |
ROI | -12.9 % | -7.9 % | -4.2 % | -5.4 % |
Economic value added (EVA) | -17.11 | -9.57 | -4.62 | -5.94 |
Solvency | ||||
Equity ratio | 22.4 % | 16.0 % | 11.9 % | 6.4 % |
Gearing | 317.3 % | 490.7 % | 697.5 % | 1388.6 % |
Relative net indebtedness % | ||||
Liquidity | ||||
Quick ratio | 15.2 | 17.4 | 19.9 | 18.9 |
Current ratio | 15.2 | 17.4 | 19.9 | 18.9 |
Cash and cash equivalents | 142.26 | 130.35 | 124.10 | 117.85 |
Capital use efficiency | ||||
Trade debtors turnover (days) | ||||
Net working capital % | ||||
Credit risk | ||||
Credit rating | C | C | C | C |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.